Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry

BACKGROUND: Long-term, real-world data are required to support the use of CT-P13 in chronic conditions such as ankylosing spondylitis. However, real-world evidence may be influenced by selection bias, which can confound outcomes. The aim of the current analysis was to confirm the long-term comparabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyoun-Ah, Lee, Eunyoung, Lee, Sun-Kyung, Park, Yong-Beom, Shin, Kichul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391390/
https://www.ncbi.nlm.nih.gov/pubmed/32696266
http://dx.doi.org/10.1007/s40259-020-00432-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391390/
https://www.ncbi.nlm.nih.gov/pubmed/32696266
http://dx.doi.org/10.1007/s40259-020-00432-z

Ejemplares similares